BRACCO DIAGNOSTICS INC.

Bracco Diagnostics Inc. specializes in the manufacturing and supply of radiopharmaceuticals and cardiac imaging systems, with a focused expertise in rubidium-82 (Rb-82) generators and associated software for positron emission tomography (PET) myocardial perfusion imaging. The company delivers critical nuclear medicine components used in the diagnosis of coronary artery disease, including Cardiogen-82 generators, infusion systems, and proprietary heart imaging software. Their technical capabilities encompass the production of short-lived radioisotopes, precision dosing systems, and integrated diagnostic platforms compliant with FDA and nuclear regulatory standards. A key differentiator is their end-to-end support for cardiac PET workflows, combining radiopharmaceutical manufacturing with equipment maintenance and software integration to ensure clinical continuity in hospital and VA settings. The contractor maintains a strong, sustained relationship with the Department of Veterans Affairs, supplying cardiac imaging systems and maintenance services for nuclear medicine departments across VA medical centers. They also support the Department of Defense with similar radiopharmaceutical and generator systems, indicating a consistent role in providing diagnostic capabilities for military and veteran healthcare networks. Their work with W40M MRC0 West further demonstrates alignment with federal procurement channels focused on medical imaging procurement. Bracco Diagnostics operates primarily under NAICS 325412 (pharmaceutical preparation manufacturing) and 325413 (in-vitro diagnostic substance manufacturing), positioning them as a niche supplier in nuclear medicine diagnostics. Their market focus is exclusively on cardiac PET radiopharmaceuticals and related hardware, serving a specialized segment of diagnostic imaging where regulatory precision and isotopic reliability are paramount. As a 2L entity headquartered in Princeton, NJ, Bracco Diagnostics Inc. is structured as a mid-tier supplier with no federal certifications listed. Their geographic presence is centralized in New Jersey, with operations scaled to meet federal healthcare demands nationwide, particularly in VA and DoD medical facilities requiring reliable, on-demand radiopharmaceutical delivery.